Skip to results

Keyword or reference number

Keyword or reference number

Last updated date

Last updated date

Area of interest

Area of interest

Type

Type

Guidance programme

Advice programme

Showing 1426 to 1450 of 2518

Published guidance, NICE advice and quality standards
TitleReference numberPublishedLast updated
End of life care for infants, children and young peopleQS160
Pembrolizumab for treating PD-L1-positive non-small-cell lung cancer after chemotherapyTA428
Pembrolizumab for treating advanced melanoma after disease progression with ipilimumabTA357
Pembrolizumab for advanced melanoma not previously treated with ipilimumabTA366
Physical health of people in prisonsQS156
HIV testing: encouraging uptakeQS157
Rehabilitation after critical illness in adultsQS158
Fertility problems: assessment and treatmentCG156
Sorafenib for treating advanced hepatocellular carcinomaTA474
Dimethyl fumarate for treating moderate to severe plaque psoriasisTA475
Paclitaxel as albumin-bound nanoparticles with gemcitabine for untreated metastatic pancreatic cancerTA476
Psoriasis: assessment and managementCG153
Fungitell for antifungal treatment stratificationMIB118
Cetuximab for treating recurrent or metastatic squamous cell cancer of the head and neckTA473
Vitamin D: supplement use in specific population groupsPH56
Radiofrequency treatment for haemorrhoidsIPG589
Methylnaltrexone bromide for treating opioid-induced constipation (terminated appraisal)TA468
Idelalisib with ofatumumab for treating chronic lymphocytic leukaemia (terminated appraisal)TA469
Holoclar for treating limbal stem cell deficiency after eye burnsTA467
Pemetrexed for the maintenance treatment of non-small-cell lung cancerTA190
Biopatch for venous or arterial catheter sitesMIB117
Developmental follow-up of children and young people born pretermNG72
Cabozantinib for previously treated advanced renal cell carcinomaTA463
Baricitinib for moderate to severe rheumatoid arthritisTA466
Urethrotech UCD for difficult or failed catheterisationMIB116

Results per page

  1. 10
  2. 25
  3. 50
  4. All